The indoor only use and rapid results means treated mice are typically easier to find and clear up, which results in low risk of environmental exposure from the product.
There is no known resistance to Ridmus Alpha, with a completely different mode of action to counter issues where mouse populations are poorly controlled by anti-coagulants.